Resistance to EGFR-Targeted Therapy: A Family Affair

Cancer Cell

Volumn 20, Issue 4, 2011, Pages 423-425

  Vlacich, Gregory ^a   Coffey, Robert J ^b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GEFITINIB; K RAS PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; SCATTER FACTOR RECEPTOR; TRASTUZUMAB;

BREAST CANCER; CANCER RESISTANCE; CELL MEMBRANE; COLORECTAL CANCER; DRUG MECHANISM; ENZYME ACTIVATION; GENE AMPLIFICATION; HEAD AND NECK CARCINOMA; HUMAN; LUNG NON SMALL CELL CANCER; ONCOGENE N RAS; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SHORT SURVEY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

EID: 80054747872     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2011.10.006     Document Type: Short Survey

References (10)

1. Arteaga C.L., O'Neill A., Moulder S.L., Pins M., Sparano J.A., Sledge G.W., Davidson N.E. Clin. Cancer Res. 2008, 14:6277-6283.
2. Atlas E., Cardillo M., Mehmi I., Zahedkargaran H., Tang C., Lupu R. Mol. Cancer Res. 2003, 1:165-175.
3. Bertotti A., Migliardi G., Galimi F., Sassi F., Torti D., Isella C., Corà D., Di Nicolantonio F., Buscarino M., Petti C., et al. Cancer Discov. 2011, Published online September 2, 2011. 10.1158/2159-8290.CD-11-0109.
4. Engelman J.A., Zejnullahu K., Mitsudomi T., Song Y., Hyland C., Park J.O., Lindeman N., Gale C.M., Zhao X., Christensen J., et al. Science 2007, 316:1039-1043.
5. Khambata-Ford S., Garrett C.R., Meropol N.J., Basik M., Harbison C.T., Wu S., Wong T.W., Huang X., Takimoto C.H., Godwin A.K., et al. J. Clin. Oncol. 2007, 25:3230-3237.
6. Personeni N., Fieuws S., Piessevaux H., De Hertogh G., De Schutter J., Biesmans B., De Roock W., Capoen A., Debiec-Rychter M., Van Laethem J.L., et al. Clin. Cancer Res. 2008, 14:5869-5876.
7. Quesnelle K.M., Grandis J.R. Clin. Cancer Res. 2011, 17:5935-5944.
8. Ritter C.A., Perez-Torres M., Rinehart C., Guix M., Dugger T., Engelman J.A., Arteaga C.L. Clin. Cancer Res. 2007, 13:4909-4919.
9. Stransky N., Egloff A.M., Tward A.D., Kostic A.D., Cibulskis K., Sivachenko A., Kryukov G.V., Lawrence M.S., Sougnez C., McKenna A., et al. Science 2011, 333:1157-1160.
10. Yonesaka K., Zejnullahu K., Okamoto I., Satoh T., Cappuzzo F., Souglakos J., Ercan D., Rogers A., Roncalli M., Takeda M., et al. Sci. Transl. Med. 2011, 3:99ra86.